Mergers and Acquisitions (M&A) Advisory

Healthcare Investment Banking

Healthcare expertise for middle-market M&A transactions. Duff & Phelps acquired Kroll in 2018 and unified under the Kroll brand in 2022.
Contact Us

Explore M&A Advisory

M&A Reports
Transactions
Experts
Connect with us on LinkedIn
Kroll Client Stories with Bob Bartell
Discover how Kroll's M&A Advisory and Investigations teams helped a family company sell their business through constructing a robust financial projection model to attract lenders and investors. Request Our Qualifications

Kroll’s Healthcare M&A practice has extensive experience in the healthcare sector, including Healthcare IT, Facilities and Real Estate, Behavioral Health and Rehabilitation, Home Health and Hospice, Pharmaceutical Services, Payor Services, Outsourced Services and Alternative Site and Ancillary Care. Our dedicated team of healthcare professionals successfully advises clients on even the most complex transactions.

Kroll Healthcare Insights
Medical Weight Loss: Evolution of the Competitive Landscape

Medical Weight Loss: Evolution of the Competitive Landscape

Innovative pharmaceutical weight loss treatments and changing post-pandemic consumer preferences have spurred a boom in the medically supervised weight loss industry. Read our insights to learn more.

Healthcare Insights - Prior Authorization

Insights on Prior Authorization

Our Healthcare experts expand on how prior authorization is innovating to address challenges throughout the sector. Learn more in our insight.

Healthcare Hot Topics Whitepaper

Home Health/Home Care/Hospice–Q2 2024

Our Healthcare experts expand on the industry dynamics and factors impacting the home health and hospice space for the second quarter, 2024. Download our Home Health/Home Care Hospice report to learn more about the trends and Kroll services.

Healthcare Hot Topics Whitepaper

Home Health, Home Care and Hospice

Our Healthcare experts expand on the industry dynamics and factors impacting the adult and pediatric home care, home health and hospice markets in H1 2024. Download our Home Health, Home Care and Hospice report to learn more about the trends and Kroll services.

Healthcare Hot Topics Whitepaper

Home Medical and Chronic Care Products and Supplies

Our Healthcare experts expand on the industry dynamics and factors impacting the home medical and chronic care equipment, products and supplies in Q2 2024. Download our Home Medical and Chronic Care Products and Supplies report to learn more about the trends and Kroll services.

Connect with us

FEATURED CASE STUDIES

Kroll's Investment Banking Team Advised AQREVA and Doctors' Resource Specialists on Its Sale to UnisLink
Kroll's Transaction Advisory Services Practice Rendered Buy-Side Financial and Tax Due Diligence to Multiplan Corporation on Its Acquisition of Benefit Solutions, LLC
Kroll’s Healthcare Investment Banking Practice Advised LSL Healthcare on its Recapitalization by 5th Century Partners
TRI-AD
Kroll's Healthcare Investment Banking Team Advised Medi-Weightloss Inc. on Its Sale to Audax Private Equity
NXC Imaging
RSA
aterian
TheraOffice
SCR Medical Transportation
Avidity Science
Emindful
The Wellness Network
Community Intervention Services
The Jersey Dental Group
Precision Orthopaedics & Sports Medicine
Xtant Medical
Neon Therapeutics
NN. Inc.
mscripts
Kroll's Investment Banking Team Advised AQREVA and Doctors' Resource Specialists on Its Sale to UnisLink
Kroll's Transaction Advisory Services Practice Rendered Buy-Side Financial and Tax Due Diligence to Multiplan Corporation on Its Acquisition of Benefit Solutions, LLC
Kroll’s Healthcare Investment Banking Practice Advised LSL Healthcare on its Recapitalization by 5th Century Partners
TRI-AD
Kroll's Healthcare Investment Banking Team Advised Medi-Weightloss Inc. on Its Sale to Audax Private Equity
NXC Imaging
RSA
aterian
TheraOffice
SCR Medical Transportation
Avidity Science
Emindful
The Wellness Network
Community Intervention Services
The Jersey Dental Group
Precision Orthopaedics & Sports Medicine
Xtant Medical
Neon Therapeutics
NN. Inc.
mscripts
Stay Ahead with Kroll

Aerospace Defense and Government Services (ADG) Investment Banking

Strategic and financial advisory for Aerospace Defense and Government Services clients worldwide.

Aerospace Defense and Government Services (ADG) Investment Banking

Consumer Investment Banking

Consumer, Retail, Food and Restaurant expertise for middle-market M&A transactions.

Consumer Investment Banking

Energy Investment Banking

Energy and Mining expertise for middle-market M&A transactions.

Energy Investment Banking

Industrials Investment Banking

Industrials expertise for middle-market M&A transactions.

Industrials Investment Banking

Business Services Investment Banking

Business services expertise for middle-market M&A transactions.

Business Services Investment Banking

Technology Investment Banking

Technology expertise for middle-market M&A transactions.

Technology Investment Banking
Explore Insights
Aerospace Defense Government Services 2024 Year in Review / 2025 Outlook
M&A Updates
Aerospace Defense Government Services 2024 Year in Review / 2025 Outlook

Aerospace Defense Government Services 2024 Year in Review / 2025 Outlook

Most segments of the ADG industry are experiencing positive momentum. Strong demand for commercial air travel with continued year-over-year growth in revenue passenger miles is benefiting operators and driving demand for aftermarket parts and services. Learn more.
Building Products & Materials Industry Insights—Winter 2025
M&A Updates
Building Products & Materials Industry Insights—Winter2025

Building Products & Materials Industry Insights—Winter 2025

High interest rates and a low supply of homes headlined the U.S. housing market in 2024. Despite three consecutive rate cuts in 2024, the average 30-year fixed-rate mortgage was 6.72% in December 2024. In response to the high-interest-rate environment, the number of single-family home starts marginally decreased by 2.1% in 2024. Read more.
Food and Beverage M&A Industry Insights–Winter 2025
M&A Updates
Food and Beverage M&A Industry Insights–Winter 2025

Food and Beverage M&A Industry Insights–Winter 2025

The food and beverage industry experienced moderately strong and consistent deal flow in Q4 2024 that was likely supported by lower interest rates in Canada and the U.S. but limited by the uncertainty stemming from the U.S. election and global conflicts. Read more.
What Are the 10 Largest REIT IPOs?
Fairness and Solvency Opinions
What Are the 10 Largest REIT IPOs?

What Are the 10 Largest REIT IPOs?

Our globally ranked Opinions Practice rendered fairness opinions on six of the ten largest REIT IPOs. Learn more.
Canadian M&A Industry Insights–Winter 2025
M&A Updates
Canadian M&A Industry Insights–Winter 2025

Canadian M&A Industry Insights–Winter 2025

Canadian M&A activity declined in volume and disclosed value in 2024 when compared to 2023. Heightened buyer precautions, challenging credit conditions and general economic uncertainty have led to an overall decrease in Canadian deal flow. Learn more.
Politicians to Take Notice of Private Debt in 2025
Valuation Outlook
Politicians to Take Notice of Private Debt in 2025

Politicians to Take Notice of Private Debt in 2025

As the world awaits Donald Trump’s second term, private credit is set to become a major force in markets and that will attract the attention of politicians. Read more.
Global Software Sector Update–Winter 2025
M&A Advisory
Global Software Sector Update–Winter 2025

Global Software Sector Update–Winter 2025

One theme throughout 2024 has been the continued momentum in generative AI infrastructure build-out, most notably by the large cloud companies Alphabet, Amazon, Microsoft and Oracle, who S&P estimate collectively invested $194 billion in capex over the year, up 52% over 2023. Read more.
Brazil Transactions Insights–Winter 2025
M&A Updates
Brazil Transactions Insights–Winter 2025

Brazil Transactions Insights–Winter 2025

In 2024, volume in Brazil M&A activity increased to 1,426 total transactions - a 1.9% increase when compared with 2023. Most active sectors include technology (software/IT), financial / insurance, energy, healthcare and food & beverages. Learn more.

Connect with us on LinkedIn

Kroll Corporate Finance and Restructuring is now on LinkedIn. Connect with us for the latest insights on investment banking, corporate finance, restructuring and insolvency solutions.
See all Transactions
Kroll's Investment Banking Team Advised AQREVA and Doctors' Resource Specialists on Its Sale to UnisLink
Sell Side Advisor
Kroll's Investment Banking Team Advised AQREVA and Doctors' Resource Specialists on Its Sale to UnisLink
August 28, 2023
Kroll's Transaction Advisory Services Practice Rendered Buy-Side Financial and Tax Due Diligence to Multiplan Corporation on Its Acquisition of Benefit Solutions, LLC
Buy Side Advisor
Kroll's Transaction Advisory Services Practice Rendered Buy-Side Financial and Tax Due Diligence to Multiplan Corporation on Its Acquisition of Benefit Solutions, LLC
June 5, 2023
Kroll’s Healthcare Investment Banking Practice Advised LSL Healthcare on Its Recapitalization by 5th Century Partners
Sell Side Advisor
Kroll’s Healthcare Investment Banking Practice Advised LSL Healthcare on Its Recapitalization by 5th Century Partners
January 5, 2023
Kroll's Healthcare Investment Banking Team Advised TRI-AD on Its Sale to Navia Benefit Solutions
Sell Side Advisor
Kroll's Healthcare Investment Banking Team Advised TRI-AD on Its Sale to Navia Benefit Solutions
December 12, 2022
Kroll's Healthcare Investment Banking Practice Advised NXC Imaging on Its Sale to Canon Medical Systems USA, Inc.
Sell Side Advisor
Kroll's Healthcare Investment Banking Practice Advised NXC Imaging on Its Sale to Canon Medical Systems USA, Inc.
August 18, 2022
Kroll's Healthcare M&A Advisory Team Advised TheraOffice on Its Sale to Netsmart
Sell Side Advisor
Kroll's Healthcare M&A Advisory Team Advised TheraOffice on Its Sale to Netsmart
April 28, 2022
Duff & Phelps, A Kroll Business, Advised Avidity Science on Sale of Lab Products and Harford Systems to Gen Cap America
Sell Side Advisor
Duff & Phelps, A Kroll Business, Advised Avidity Science on Sale of Lab Products and Harford Systems to Gen Cap America
September 16, 2021
Duff & Phelps, A Kroll Business, Advised SCR Medical Transportation on Its Sale to Beacon Mobility, a Portfolio Company of Audax Private Equity
Sell Side Advisor
Duff & Phelps, A Kroll Business, Advised SCR Medical Transportation on Its Sale to Beacon Mobility, a Portfolio Company of Audax Private Equity
September 13, 2021
Duff & Phelps, A Kroll Business, Advised eMindful on Its Sale to Wondr Health
Sell Side Advisor
Duff & Phelps, A Kroll Business, Advised eMindful on Its Sale to Wondr Health
August 19, 2021
Duff & Phelps, A Kroll Business, Advised The Wellness Network on Its Sale to WebMD Health Corp.
Sell Side Advisor
Duff & Phelps, A Kroll Business, Advised The Wellness Network on Its Sale to WebMD Health Corp.
August 3, 2021

Kroll is headquartered in New York with offices around the world.

One World Trade Center
285 Fulton Street, 31st Floor
New York NY 10007
+1 212 593 1000
Sign up to receive periodic news, reports, and invitations from Kroll. Our privacy policy describes how your data will be processed.

More About Kroll

More About Kroll
© 2025 Kroll, LLC. All rights reserved. Kroll is not affiliated with Kroll Bond Rating Agency, Kroll OnTrack Inc. or their affiliated businesses. Read more.